Optimizing treatment models for uterine cancers
Prospective, Tricentric Open Trial on the Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
This study is testing new ways to create personalized treatment plans for patients with uterine cancer who are having surgery to see if it can improve their outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 580 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital Tuebingen Academic / other |
| Locations | 1 site (Tübingen) |
| Trial ID | NCT03624712 on ClinicalTrials.gov |
What this trial studies
This study evaluates the clinical, therapeutic, and prognostic relevance of new experimental results in patients with uterine neoplasms. It aims to optimize therapeutic models and develop a new algorithm for creating personalized treatment plans. The study focuses on patients with confirmed uterine malignancies who are undergoing surgical therapy. Data will be collected to assess the effectiveness of these new approaches in improving patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with confirmed uterine malignancies who are eligible for surgical treatment.
Not a fit: Patients with severe acute diseases, psychiatric disorders, or those unable to understand the study's nature may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective and personalized treatment strategies for patients with uterine cancers.
How similar studies have performed: Other studies have shown promise in optimizing treatment models for cancer, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma) * If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery * Written consent * Willingness and ability to participate in all study-specific procedures * Age ≥ 18 years Exclusion Criteria: * Severe and acute general disease in the last 4 weeks * Acute or chronic psychiatric disorders * Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)
Where this trial is running
Tübingen
- University Hospital Tuebingen, Department of Women's Health — Tübingen, Germany (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.